POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.

Massachusetts Requires Naloxone Stations Across All MBTA Subway Lines

Original title: An Act directing the Massachusetts Bay Transportation Authority to place naloxone in subway stations

Last action · August 13, 2026: Bill reported favorably by committee and referred to the committee on Senate Ways and MeansSponsors: John Keenan and 2 others

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Would Do

The Massachusetts Bay Transportation Authority is required to install accessible, unalarmed boxes containing nasal spray at all Blue, Green, Orange, and Red Line subway stations.

Why it matters

Expands emergency overdose-reversal medication access for transit riders across the rapid transit network and mandates a state reporting evaluation on program costs and efficacy within 18 months.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

MBTA subway riders

Commuters gain immediate access to emergency overdose-reversal medication and instructional signage across all rapid transit stations.

Directly affected

Massachusetts Bay Transportation Authority

The transit agency must purchase, install, and conduct daily checks on naloxone boxes, and subsequently prepare and file an evaluation report.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Where will the naloxone boxes be located within the subway system?
Two freestanding unalarmed boxes will be placed at all stations across the MBTA Blue, Green, Orange, and Red lines.
What is inside each naloxone box?
Each box contains 2 units of 4 milligram spray.
Who evaluates whether the program is working?
The MBTA must file a report evaluating the program's efficacy, benefits, and costs to legislative leaders and committee chairs between 12 and 18 months after the program starts.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

6 actions
  1. Aug 13, 2026SenateCommittee
    Bill reported favorably by committee and referred to the committee on Senate Ways and Means
  2. Apr 30, 2026Senate
    Reporting date extended to Friday July 31, 2026
  3. Feb 19, 2026Senate
    Reporting date extended to Tuesday March 31, 2026
  4. Sep 25, 2025Joint
    Hearing scheduled for 10/07/2025 from 11:00 AM-01:00 PM in A-1
  5. Feb 27, 2025House
    House concurred
  6. Feb 27, 2025SenateCommittee
    Referred to the committee on Transportation

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

Orange Line, Massachusetts Bay Transportation Authority, Blue Line and 2 more
otherOrange Line“MBTA rapid transit line where stations must have naloxone boxes.”Map →
OrganizationMassachusetts Bay Transportation Authority“Required to install and maintain naloxone boxes and file reports.”Map →
otherBlue Line“MBTA rapid transit line where stations must have naloxone boxes.”Map →
otherRed Line“MBTA rapid transit line where stations must have naloxone boxes.”Map →
otherGreen Line“MBTA rapid transit line where stations must have naloxone boxes.”Map →

Sources

Open source document

malegislature.gov

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz40
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record